This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Apolipoprotein genotyping in Alzheimer 's disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A consensus document published in 1996 provides guidance on the use of apolipoprotein E genotyping in Alzheimer's disease. The main points of the report were (1):

  • apoE genotyping is not recommended for risk assessment in individuals without symptoms or signs of Alzheimer's disease
  • apoE-4 is more common in patients with Alzheimer's disease than in either the normal population or those patients with non-Alzheimer's dementia; for these reasons some physicians may wish to use apoE genotyping as an adjunct in the diagnosis of Alzheimer's disease
  • apoE genotyping should not be used as the sole diagnostic test in Alzheimer's disease
  • the social and financial implications of apoE genotyping should be considered before investigating a patient.

Reference:

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page